CHAD Antikörper (AA 23-359)
-
- Target Alle CHAD Antikörper anzeigen
- CHAD (Chondroadherin (CHAD))
-
Bindungsspezifität
- AA 23-359
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser CHAD Antikörper ist unkonjugiert
-
Applikation
- ELISA, Immunohistochemistry (IHC)
- Kreuzreaktivität
- Human
- Aufreinigung
- Antigen Affinity Purified
- Immunogen
- Recombinant Human Chondroadherin protein (23-359AA)
- Isotyp
- IgG
- Top Product
- Discover our top product CHAD Primärantikörper
-
-
- Applikationshinweise
- Recommended dilution: IHC:1:20-1:200,
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4 - Konservierungsmittel
- ProClin
- Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C,-80 °C
- Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
- Target
- CHAD (Chondroadherin (CHAD))
- Andere Bezeichnung
- CHAD (CHAD Produkte)
- Synonyme
- CHAD antikoerper, zgc:63475 antikoerper, SLRR4A antikoerper, chondroadherin antikoerper, CHAD antikoerper, chad antikoerper, Chad antikoerper
- Hintergrund
-
Background: Promotes attachment of chondrocytes, fibroblasts, and osteoblasts. This binding is mediated (at least for chondrocytes and fibroblasts) by the integrin alpha(2)beta(1). May play an important role in the regulation of chondrocyte growth and proliferation (By similarity).
Aliases: Cartilage leucine rich protein antibody, Cartilage leucine-rich protein antibody, Chad antibody, CHAD_HUMAN antibody, Chondroadherin antibody, Chondroadherin proteoglycan antibody, SLRR4A antibody
- UniProt
- O15335
-